IJNRD Research Journal

WhatsApp
Click Here

WhatsApp editor@ijnrd.org
IJNRD
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.76

Issue per Year : 12

Volume Published : 9

Issue Published : 94

Article Submitted :

Article Published :

Total Authors :

Total Reviewer :

Total Countries :

Indexing Partner

Join RMS/Earn 300

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: To Study Nishamalaki sustained Release Tablet as an antidiabetic
Authors Name: Bhumika Eknath Ahirrao , Vaishali B. Bhamare
Download E-Certificate: Download
Author Reg. ID:
IJNRD_185961
Published Paper Id: IJNRD2301115
Published In: Volume 8 Issue 1, January-2023
DOI:
Abstract: Amla (Emblica officinalis) and haldi (Curcuma longa) are combined to form "Nishamalaki" or "Nisha Amalaki," which is used to cure diabetes. It works well for diabetes-related neuropathy and urinary problems in addition to diabetes itself. One of the most important health issues facing the world today is diabetes mellitus. The population of diabetic Indians has been shown to have poor glycemic control. All health agencies have identified diabetes as one of four priority non-communicable diseases for prevention and control. The goal of the current report is to examine the potential uses of an effective herbal combination of amla and haldi as a sustained release tablet for Type 2 Diabetes mellitus prevention and health promotion.
Keywords: Nishamalaki, diabetes mellitus, amla, haldi.
Cite Article: "To Study Nishamalaki sustained Release Tablet as an antidiabetic", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 1, page no.a103-a104, January-2023, Available :http://www.ijnrd.org/papers/IJNRD2301115.pdf
Downloads: 000118745
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID:IJNRD2301115
Registration ID: 185961
Published In: Volume 8 Issue 1, January-2023
DOI (Digital Object Identifier):
Page No: a103-a104
Country: dindori, Nashik, Maharashtra, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2301115
Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2301115
Share Article:
Share

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijnrd.org
Semantic Scholar Microsaoft Academic ORCID Zenodo
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX PUBLON
DRJI SSRN Scribd DocStoc

ISSN Details

ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI
How to Get DOI? DOI

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Join RMS/Earn 300

IJNRD